KaydedilenlerDerginizi ekleyin

Dergiler / Medical Science and Discovery / 2016 / Cilt: 3 Sayı: 10

Thyrotoxicosis formation due to functioning metastatic follicular thyroid cancer

Thyrotoxicosis due to functioning metastatic follicular thyroid cancer

Sadiye Altun TUZCU
Faruk KİLİNC
Zafer PEKKOLAY
Hikmet SOYLU
Alpaslan Kemal TUZCU
Sayfa
339–41
Yayın Tarihi
2016-10-15
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Thyrotoxicosis is a common condition associated with excess circulating thyroid hormones.
📊
Temel Bulgular & Veri:Most of patients with functional thyroid cancer metastases have had normal thyroxine (T4) concentrations but high serum triiodothyronine (T3-thyrotoxicosis).
💡
Sonuç & Katkı:In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:metastatic follicular thyroid cancer · thyrotoxicosis

Abstract

Thyrotoxicosis is a common condition associated with excess circulating thyroid hormones. Rarely, thyrotoxicosis can be developing due to functioning metastatic thyroid carcinoma. Most of patients with functional thyroid cancer metastases have had normal thyroxine (T4) concentrations but high serum triiodothyronine (T3-thyrotoxicosis). Inappropriately supressed TSH levels with normal T4 levels may be helpful to suspect T3 thyrotoxicosis. In this case report we present a case of thyrotoxicosis due to metastatic follicular thyroid cancer with a huge metastatic lesion.

🔖

Bu Makaleye Atıf Yap

TUZCU, S. A., KİLİNC, F., PEKKOLAY, Z., SOYLU, H., TUZCU, A. K. (2016). Thyrotoxicosis formation due to functioning metastatic follicular thyroid cancer. Medical Science and Discovery, Cilt: 3 Sayı: 10, 339–41. https://ajindex.com/articles/1003060

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014; 21:349:g 5128. Nakashima T, Inoue K, Shiro-ozu A, et al. Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3-toxicosis. Metabolismi 1981;30:327-330.
  2. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
  3. Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab.1997; 82:735-738.
  4. Miyauchi A, Takamura Y, Ito Y, et al. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. J Clin Endocrinol Metab 2008; 93:2239. Kasagi K, Takeuchi R, Miyamoto S, et al. Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin Endocrinol (Oxf) 1994; 40:429.